Latigo Biotherapeutics Inc.(LTGO)

Medical - Pharmaceuticals · Thousand Oak, CA

$16.43-0.20 (-1.20%)

Delayed quote: Oct 6, 2026, 2:45 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T18:47:06.112Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:47:06.112Z.

Quote observation: 2026-10-06T18:45:04.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 988,359,035
Total debt: N/A
Cash: N/A
TTM operating income: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LTGO EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

LTGO Competitors' EV/EBIT Ratio

LTGO

Latigo Biotherapeutics Inc.

Current

Market Cap

$988.36M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGTX

MeiraGTx Holdings plc

vs LTGO

Market Cap

$989.07M

EV/EBIT Ratio

5.21x

TTM Avg

6.47x

3Y Avg

6.47x

5Y Avg

6.47x

PRCT

PROCEPT BioRobotics Corporation

vs LTGO

Market Cap

$986.26M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LBRX

LB Pharmaceuticals Inc Common Stock

vs LTGO

Market Cap

$988.77M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VOR

Vor Biopharma Inc.

vs LTGO

Market Cap

$996.36M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PCRX

Pacira BioSciences, Inc.

vs LTGO

Market Cap

$978.86M

EV/EBIT Ratio

64.25x

TTM Avg

51.40x

3Y Avg

38.19x

5Y Avg

39.85x

CGEM

Cullinan Therapeutics, Inc.

vs LTGO

Market Cap

$1.01B

EV/EBIT Ratio

N/A

TTM Avg

2.12x

3Y Avg

2.12x

5Y Avg

2.12x

AKTS

Aktis Oncology, Inc.

vs LTGO

Market Cap

$964.49M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMTX

Immatics N.V.

vs LTGO

Market Cap

$1.02B

EV/EBIT Ratio

N/A

TTM Avg

40.23x

3Y Avg

40.23x

5Y Avg

40.23x

CSTL

Castle Biosciences, Inc.

vs LTGO

Market Cap

$1.02B

EV/EBIT Ratio

N/A

TTM Avg

59.55x

3Y Avg

59.55x

5Y Avg

78.29x

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Latigo Biotherapeutics Inc. (LTGO)	$988.36M	N/A	N/A	N/A	N/A
MeiraGTx Holdings plc (MGTX)vs ›	$989.07M	5.21x	6.47x	6.47x	6.47x
PROCEPT BioRobotics Corporation (PRCT)vs ›	$986.26M	N/A	N/A	N/A	N/A
LB Pharmaceuticals Inc Common Stock (LBRX)vs ›	$988.77M	N/A	N/A	N/A	N/A
Vor Biopharma Inc. (VOR)vs ›	$996.36M	N/A	N/A	N/A	N/A
Pacira BioSciences, Inc. (PCRX)vs ›	$978.86M	64.25x	51.40x	38.19x	39.85x
Cullinan Therapeutics, Inc. (CGEM)vs ›	$1.01B	N/A	2.12x	2.12x	2.12x
Aktis Oncology, Inc. (AKTS)vs ›	$964.49M	N/A	N/A	N/A	N/A
Immatics N.V. (IMTX)vs ›	$1.02B	N/A	40.23x	40.23x	40.23x
Castle Biosciences, Inc. (CSTL)vs ›	$1.02B	N/A	59.55x	59.55x	78.29x

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

LTGO EV/EBIT Ratio Metrics

LTGO Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics